NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates.
de Castro Barbosa ML, da Conceicao RA, Fraga AGM, Camarinha BD, de Carvalho Silva GC, Lima AGF, Cardoso EA, de Oliveira Freitas Lione V.
de Castro Barbosa ML, et al. Among authors: lima agf.
Anticancer Agents Med Chem. 2017;17(4):483-490. doi: 10.2174/1871520616666160729112854.
Anticancer Agents Med Chem. 2017.
PMID: 27481554
Review.